Brown Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74M Buy
94,160
+9,358
+11% +$835K 0.02% 445
2026
Q1
$6.09M Sell
84,802
-3,637
-4% -$280K 0.01% 493
2025
Q4
$7.02M Sell
88,439
-3,313
-4% -$261K 0.01% 475
2025
Q3
$6.92M Sell
91,752
-4,024
-4% -$276K 0.01% 477
2025
Q2
$6.61M Sell
95,776
-2,820
-3% -$185K 0.01% 470
2025
Q1
$6.68M Sell
98,596
-33,766
-26% -$2.02M 0.01% 466
2024
Q4
$5.94M Buy
132,362
+4,473
+3% +$251K 0.01% 503
2024
Q3
$8.04M Sell
127,889
-21,438
-14% -$1.25M 0.01% 448
2024
Q2
$8.82M Sell
149,327
-56,876
-28% -$3.56M 0.01% 429
2024
Q1
$16.4M Sell
206,203
-71,797
-26% -$5.48M 0.02% 346
2023
Q4
$22M Sell
278,000
-40,839
-13% -$2.91M 0.03% 310
2023
Q3
$22.3M Sell
318,839
-17,686
-5% -$1.25M 0.04% 298
2023
Q2
$23.3M Sell
336,525
-19,033
-5% -$1.35M 0.04% 296
2023
Q1
$26.4M Buy
355,558
+17,298
+5% +$1.45M 0.04% 280
2022
Q4
$31.5M Sell
338,260
-1,049
-0.3% -$101K 0.06% 256
2022
Q3
$32.4M Buy
339,309
+18,975
+6% +$1.88M 0.06% 241
2022
Q2
$29.7M Buy
320,334
+39,669
+14% +$3.87M 0.06% 258
2022
Q1
$28.4M Buy
280,665
+6,130
+2% +$644K 0.04% 274
2021
Q4
$28.3M Buy
274,535
+134,988
+97% +$12.5M 0.04% 281
2021
Q3
$11.8M Buy
139,547
+3,166
+2% +$265K 0.02% 357
2021
Q2
$11.4M Buy
136,381
+2,376
+2% +$195K 0.02% 360
2021
Q1
$10.1M Sell
134,005
-5,403
-4% -$394K 0.02% 350
2020
Q4
$9.52M Sell
139,408
-14,188
-9% -$923K 0.02% 351
2020
Q3
$8.97M Sell
153,596
-4,452
-3% -$277K 0.02% 326
2020
Q2
$10.3M Sell
158,048
-3,740
-2% -$236K 0.02% 303
2020
Q1
$9.6M Buy
161,788
+5,727
+4% +$382K 0.03% 287
2019
Q4
$11.6M Buy
156,061
+10,583
+7% +$743K 0.03% 305
2019
Q3
$9.18M Buy
145,478
+1,275
+0.9% +$75.6K 0.03% 336
2019
Q2
$7.86M Sell
144,203
-269,661
-65% -$14.5M 0.02% 352
2019
Q1
$22.3M Sell
413,864
-7,437
-2% -$459K 0.06% 232
2018
Q4
$27.6M Sell
421,301
-29,020
-6% -$2.17M 0.09% 192
2018
Q3
$35.5M Buy
450,321
+6,639
+1% +$475K 0.1% 185
2018
Q2
$28.6M Buy
443,682
+172,053
+63% +$11.3M 0.09% 202
2018
Q1
$16.9M Buy
271,629
+51,292
+23% +$3.68M 0.05% 246
2017
Q4
$16M Sell
220,337
-129,593
-37% -$9.42M 0.05% 258
2017
Q3
$28.5M Sell
349,930
-5,793
-2% -$458K 0.09% 187
2017
Q2
$28.6M Buy
355,723
+35,449
+11% +$2.8M 0.09% 188
2017
Q1
$25.1M Buy
320,274
+63,534
+25% +$5.07M 0.09% 188
2016
Q4
$20.3M Buy
256,740
+59,809
+30% +$4.84M 0.07% 206
2016
Q3
$17.5M Buy
196,931
+8,036
+4% +$759K 0.06% 220
2016
Q2
$18.1M Buy
188,895
+22,674
+14% +$2.26M 0.06% 207
2016
Q1
$17.2M Buy
166,221
+40,355
+32% +$3.92M 0.06% 200
2015
Q4
$12.3M Buy
125,866
+944
+0.8% +$92.5K 0.04% 252
2015
Q3
$12.1M Sell
124,922
-3,762
-3% -$395K 0.04% 244
2015
Q2
$13.5M Buy
128,684
+6,855
+6% +$700K 0.04% 242
2015
Q1
$12.6M Sell
121,829
-1,743
-1% -$176K 0.04% 252
2014
Q4
$11.9M Buy
123,572
+4,644
+4% +$409K 0.04% 252
2014
Q3
$9.46M Buy
118,928
+307
+0.3% +$24.2K 0.03% 273
2014
Q2
$8.94M Sell
118,621
-8,454
-7% -$639K 0.03% 274
2014
Q1
$9.51M Sell
127,075
-3,069
-2% -$217K 0.03% 266
2013
Q4
$9.31M Buy
130,144
+5,906
+5% +$379K 0.03% 259
2013
Q3
$7.05M Buy
124,238
+9,106
+8% +$543K 0.03% 274
2013
Q2
$6.58M Buy
+115,132
New +$6.67M 0.03% 268

Other funds holding CVS

Brown Advisory's CVS Position: Q2 2026 in Review

Brown Advisory increased its CVS Health (CVS) stake by 11% in Q2 2026, buying an estimated $835K and bringing the position to 94,160 shares worth $9.74M. The position accounts for 0.02% of the portfolio, ranked #445.

Brown Advisory first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.5M in Q3 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Brown Advisory held 94,160 shares of CVS Health worth $9.74M as of Q2 2026.
  • Brown Advisory bought 9,358 CVS Health shares in Q2 2026, an estimated $835K.
  • CVS Health made up 0.02% of Brown Advisory's portfolio in Q2 2026, its #445 holding.
  • Brown Advisory first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Brown Advisory's CVS Health position peaked at $35.5M in Q3 2018.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.